We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 0616C
GlaxoSmithKline PLC
16 January 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Ms E Walmsley === ====================== ================================= b) Position/status Chief Executive Officer === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ----------- ---------- GBP13.306 87.861 ----------- ---------- GBP13.306 87.861 ----------- ---------- GBP13.306 217.580 ----------- ---------- GBP13.306 217.564 ----------- ---------- GBP13.306 236.894 ----------- ---------- GBP13.306 236.879 ----------- ---------- === ====================== ================================= d) Aggregated information Aggregated volume Price 1,084.639 GBP13.306 === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr R G Connor === ====================== ================================= b) Position/status President, Global Manufacturing & Supply === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ----------- ---------- GBP13.306 64.344 ----------- ---------- GBP13.306 64.344 ----------- ---------- GBP13.306 147.828 ----------- ---------- GBP13.306 123.348 ----------- ---------- GBP13.306 123.334 ----------- ---------- === ====================== ================================= d) Aggregated information Aggregated volume Price 523.198 GBP13.306 === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr L Debruyne === ====================== ================================= b) Position/status President, Global Vaccines === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ----------- ---------- GBP13.306 207.321 ----------- ---------- GBP13.306 207.306 ----------- ---------- === ====================== ================================= d) Aggregated information Aggregated volume Price 414.627 GBP13.306 === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr S Dingemans === ====================== ================================= b) Position/status Chief Financial Officer === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793
=== ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ----------- ---------- GBP13.306 122.724 ----------- ---------- GBP13.306 122.707 ----------- ---------- GBP13.306 287.332 ----------- ---------- GBP13.306 287.316 ----------- ---------- GBP13.306 215.211 ----------- ---------- GBP13.306 215.211 ----------- ---------- === ====================== ================================= d) Aggregated information Aggregated volume Price 1,250.501 GBP13.306 === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr N Hirons === ====================== ================================= b) Position/status SVP, Global Ethics & Compliance === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ----------- ---------- GBP13.306 45.052 ----------- ---------- GBP13.306 45.052 ----------- ---------- GBP13.306 106.239 ----------- ---------- GBP13.306 106.239 ----------- ---------- GBP13.306 77.966 ----------- ---------- GBP13.306 77.951 ----------- ---------- === ====================== ================================= d) Aggregated information Aggregated volume Price 458.499 GBP13.306 === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === =========================================================== a) Name Mr B McNamara === ====================== =================================== b) Position/status CEO, GSK Consumer Healthcare === ====================== =================================== c) Initial notification/ Initial notification amendment === ====================== =================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =========================================================== a) Name GlaxoSmithKline plc === ====================== =================================== b) LEI 5493000HZTVUYLO1D793 === ====================== =================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =========================================================== a) Description American Depositary Shares ('ADSs') of the financial ISIN: US37733W1053 instrument === ====================== =================================== b) Nature of Acquisition of ADSs following the transaction the re-investment of dividends paid to shareholders on 11 January 2018 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan. === ====================== =================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $36.84 87.876 --------- ---------- === ====================== =================================== d) Aggregated information Aggregated volume Price 87.876 $36.84 === ====================== =================================== e) Date of the 2018-01-11 transaction === ====================== =================================== f) Place of the New York Stock Exchange (XNYS) transaction === ====================== =================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr D S Redfern === ====================== ================================= b) Position/status Chief Strategy Officer === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ----------- ----------
GBP13.306 72.194 ----------- ---------- GBP13.306 72.194 ----------- ---------- GBP13.306 135.207 ----------- ---------- GBP13.306 135.207 ----------- ---------- GBP13.306 98.121 ----------- ---------- GBP13.306 98.106 ----------- ---------- === ====================== ================================= d) Aggregated information Aggregated volume Price 611.029 GBP13.306 === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Ms C Thomas === ====================== ================================= b) Position/status SVP, Human Resources === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ----------- ---------- GBP13.306 97.174 ----------- ---------- GBP13.306 97.158 ----------- ---------- GBP13.306 197.805 ----------- ---------- GBP13.306 197.805 ----------- ---------- GBP13.306 147.686 ----------- ---------- GBP13.306 147.686 ----------- ---------- === ====================== ================================= d) Aggregated information Aggregated volume Price 885.314 GBP13.306 === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Mr P C Thomson === ====================== ================================= b) Position/status President, Global Affairs === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ----------- ---------- GBP13.306 66.002 ----------- ---------- GBP13.306 121.024 ----------- ---------- GBP13.306 92.975 ----------- ---------- === ====================== ================================= d) Aggregated information Aggregated volume Price 280.001 GBP13.306 === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== ================================= 1. Details of PDMR/person closely associated with them ('PCA') === =========================================================== a) Name Mr D E Troy === ====================== =================================== b) Position/status SVP & General Counsel === ====================== =================================== c) Initial notification/ Initial notification amendment === ====================== =================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =========================================================== a) Name GlaxoSmithKline plc === ====================== =================================== b) LEI 5493000HZTVUYLO1D793 === ====================== =================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =========================================================== a) Description American Depositary Shares ('ADSs') of the financial ISIN: US37733W1053 instrument === ====================== =================================== b) Nature of Acquisition of ADSs following the transaction the re-investment of dividends paid to shareholders on 11 January 2018 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan. === ====================== =================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ---------- $36.84 50.006 --------- ---------- $36.84 50.006 --------- ---------- $36.84 112.593 --------- ---------- $36.84 112.593 --------- ---------- $36.84 93.253 --------- ---------- $36.84 93.239 --------- ---------- === ====================== =================================== d) Aggregated information Aggregated volume Price 511.690 $36.84 === ====================== ===================================
e) Date of the 2018-01-11 transaction === ====================== =================================== f) Place of the New York Stock Exchange (XNYS) transaction === ====================== =================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================= a) Name Dr P J T Vallance === ====================== ================================= b) Position/status President, R&D === ====================== ================================= c) Initial notification/ Initial notification amendment === ====================== ================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================= a) Name GlaxoSmithKline plc === ====================== ================================= b) LEI 5493000HZTVUYLO1D793 === ====================== ================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================= a) Description Ordinary shares of 25 pence each of the financial ('Ordinary Shares') instrument ISIN: GB0009252882 === ====================== ================================= b) Nature of Acquisition of Ordinary Shares the transaction following the re-investment of dividends paid to shareholders on 11 January 2018 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ====================== ================================= c) Price(s) and Price(s) Volume(s) volume(s) ----------- ---------- GBP13.306 143.039 ----------- ---------- GBP13.306 143.039 ----------- ---------- GBP13.306 232.681 ----------- ---------- GBP13.306 232.681 ----------- ---------- GBP13.306 160.411 ----------- ---------- GBP13.306 160.411 ----------- ---------- === ====================== ================================= d) Aggregated information Aggregated volume Price 1,072.262 GBP13.306 === ====================== ================================= e) Date of the 2018-01-11 transaction === ====================== ================================= f) Place of the London Stock Exchange (XLON) transaction === ====================== =================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDQLFFVFFZBBD
(END) Dow Jones Newswires
January 16, 2018 12:48 ET (17:48 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions